- Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial2014 | First Faculty of Medicine
- Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry2021 | First Faculty of Medicine, Central Library of Charles University
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus2019 | First Faculty of Medicine
- Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire2011 | First Faculty of Medicine
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial2013 | First Faculty of Medicine
- Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia2014 | First Faculty of Medicine
- Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study2013 | First Faculty of Medicine
- The difficult case of rheumatoid arthritis with extraarticular manifestations and multiple intolerance of therapy2012 | Faculty of Medicine in Hradec Králové
- Secukinumab in the treatment of ankylosing spondylitis2019 | First Faculty of Medicine
- Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study2015 | First Faculty of Medicine
- Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein2018 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Vaccination of the patients with autoimmune inflammatory disease on treatment with new biologics and JAK inhibitors2019 | First Faculty of Medicine
- Spondyloarthritis2020 | First Faculty of Medicine, Third Faculty of Medicine
- 19 Psoriasis2023 | Third Faculty of Medicine
- Long‑term effect and safety of secukinumab in the therapy of ankylosing spondylitis – a case study2023 | First Faculty of Medicine
- A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study2016 | First Faculty of Medicine
- Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?2019 | First Faculty of Medicine
- Inhibitors of Janus kinases in the therapy of rheumatoid arthritis2019 | First Faculty of Medicine
- Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response2021 | First Faculty of Medicine, Faculty of Science
- Recommendations of the Czech Society for Rheumatology for the treatment of axial spondyloarthritis Part II. Non-pharmacological treatment Recommendations of the Czech Society for Rheumatology for the treatment of axial spondyloarthritis Part II. Non-pharmacological treatment2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Risk of prognostic serious infections and unapparent immunodeficiency in systemic lupus erythematosus2019 | Faculty of Medicine in Hradec Králové
- Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study2019 | First Faculty of Medicine, Central Library of Charles University
- Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry2020 | First Faculty of Medicine
- Multidomain efficacy of secukinumab in psoriatic arthritis2023 | First Faculty of Medicine
- Methotrexate impact on radiographic progression in biologic-treated rheumatoid arthritis under clinical remission: A case report on monozygotic Caucasian twins2016 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Efficacy of the first and subsequent treatment lines with adalimumab in patients with rheumatoid arthritis: data analysis from the Czech National Registry ATTRA2016 | Publication without faculty affiliation
- Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis2020 | First Faculty of Medicine
- MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis2016 | First Faculty of Medicine, Faculty of Science
- Teleconsultation in rheumatology: A literature review and opinion paper2023 | First Faculty of Medicine
- Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access2017 | First Faculty of Medicine
